DLA Piper Guides Takeda In €520M Biopharma Acquisition

By Matthew Guarnaccia (January 5, 2018, 3:56 PM EST) -- Takeda Pharmaceutical Co. said Friday it is putting a plan in motion to take over Belgian biopharmaceutical company TiGenix NV with an approximately €520 million ($626 million) deal, steered by DLA Piper, that would see the drug giant take an even bigger step into the gastrointestinal therapy field....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!